Biora Therapeutics Inc (BIOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 435 | 182 | 463 | 167 | 106 |
| Gross Profit | 435 | 182 | 463 | 167 | 106 |
| Operating Expenses | 20,594 | 30,743 | 36,116 | 31,631 | 28,487 |
| Operating Income | -20,159 | -30,561 | -35,653 | -31,464 | -28,381 |
| Interest Expense | 2,186 | 3,458 | 3,502 | 3,520 | 2,687 |
| Other Income | -60,561 | -2,855 | -2,245 | 17,523 | -21,294 |
| Pre-tax Income | -82,906 | -36,874 | -41,400 | -17,461 | -52,362 |
| Income Tax | -119 | N/A | N/A | N/A | 164 |
| Net Income Continuous | -82,787 | -36,874 | -41,400 | -17,461 | -52,526 |
| Net Income Discontinuous | -10,087 | -6,870 | -37,131 | -14,803 | -23,002 |
| Net Income | $-92,874 | $-43,744 | $-78,531 | $-32,264 | $-75,528 |
| EPS Basic Total Ops | -14.00 | -11.50 | -30.75 | -14.00 | -38.25 |
| EPS Basic Continuous Ops | -12.50 | -9.50 | -16.25 | -7.50 | -26.75 |
| EPS Basic Discontinuous Ops | -1.50 | -1.75 | -14.50 | -6.50 | -11.75 |
| EPS Diluted Total Ops | -14.00 | -11.50 | -30.75 | -14.00 | -38.25 |
| EPS Diluted Continuous Ops | -12.50 | -9.50 | -16.25 | -7.50 | -26.75 |
| EPS Diluted Discontinuous Ops | -1.50 | -1.75 | -14.50 | -6.50 | -11.75 |
| EBITDA(a) | $-19,421 | $-34,008 | $-30,766 | $-30,633 | $-26,245 |